Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Gene Editing
Products 11 to 20 of 33
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
GM Tomato Resistance (Ptr 1 gene) to Bacterial Speck Disease
by
Boyce Thompson Institute
Biotech components:
Gene Editing
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (3 years ago)
Date last modified:
2020/12/18 14:38 (3 years ago)
Known funding amount:
N/A
Funding types:
Research Institution
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Research Institution
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Hornless cattle
by
Recombinetics
Biotech components:
Animal
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/01/21 15:00 (4 years ago)
Date last modified:
2020/01/21 15:00 (4 years ago)
Known funding amount:
34,000,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Animal
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Methane bioconversion: 1,4 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: 2,3 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
+
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: Farnesene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane Bioconversion: Isobutanol
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/16 16:29 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: Isobutyraldehyde
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: isoprene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Chemical
+
Other (Industrial)
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Neuroscience Chip
by
Koniku
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Government
+
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
1,650,980 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
+
Security
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Design
+
Food
+
Threat detection
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Non-browning avocado
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (5 years ago)
Date last modified:
2019/09/12 14:31 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
